The Department of Hepatobiliary Surgery serves as a major diagnosis and treatment center for complex hepatopancreatobiliary diseases in South China. Guided by the principle of precision and characterized by minimally invasive techniques, it is a leading explorer and promoter of standardized procedures in China's minimally invasive hepatopancreatobiliary surgery. In 2013, the department performed Asia's first laparoscopic-assisted portal vein ligation combined with staged hepatectomy (ALPPS) for hepatocellular carcinoma. Utilizing ALPPS technology, the three-year survival rate for intermediate to advanced liver cancer has been increased to 55%. The department pioneered the standardization and proceduralization of laparoscopic right hemihepatectomy, right posterior sectionectomy, and segment 7 resection both domestically and internationally. As a primary training base for laparoscopic liver surgery in China, it has trained nearly a thousand surgeons over the past five years, including participants from Taiwan. It was also one of the earliest units in South China to perform laparoscopic pancreatoduodenectomy and the first in China to complete all types of laparoscopic pancreatic surgeries. Additionally, the department excels in the multidisciplinary diagnosis and treatment of complex hepatopancreatobiliary tumors and in biliary tract injury repair. Over the past decade, the "Lingnan International Summit Forum on Minimally Invasive Hepatopancreatobiliary Surgery," founded by the department, has become a renowned academic exchange platform both domestically and internationally. In 2019, leveraging the IHPA China Chapter ERAS Committee and the Hubei Chen Xiaoping Science and Technology Development Foundation, the department initiated and promoted the establishment and certification of national-level ERAS standard wards in hepatobiliary surgery, contributing to the advancement of ERAS practices in China.